220
Participants
Start Date
May 31, 2003
Primary Completion Date
February 28, 2005
Study Completion Date
February 28, 2005
PCV7, Prevnar®
Randomized to receive 0.1mL, 0.5mL, 1.0mL or 2.0mL at the enrollment visit, followed by 0.1mL PPV23 12 months later.
Pneumovax 23
Randomized to receive 0.5mL at the enrollment visit, followed by 0.1mL PPV23 12 months later.
Group Health Research Institute, Seattle
VA Puget Sound Health Care System, Seattle
Centers for Disease Control and Prevention
FED
Kaiser Permanente
OTHER